Each year, tens of thousands of Indian women die from breast cancer not because medicine lacks answers, but because the disease is found too late. The pandemic has deepened this ancient tragedy: fear of one illness has caused women to turn away from the care that might have caught another in time. Across India, the six-month silences of lockdown are now arriving at hospital doors as stage-two and stage-three diagnoses — a delayed reckoning that will shape survival statistics for years to come.
Delayed screenings fuel rise in advanced breast cancer cases amid Covid fears
Approximately 70,000 Indian women die annually from breast cancer due to delayed detection; pandemic-driven delays are pushing more cases to life-threatening advanced stages.
The cancer had progressed from treatable to life-threatening
Mark
Why did hospital visits drop so dramatically? Was it just fear, or were hospitals actually closed?
Mimi
Both. Lockdowns restricted movement, but the real driver was fear. Women were terrified of catching Covid in a hospital. They didn't know if the building was safe. So they stayed home and hoped the lump would go away.
Mark
And when they finally came back, the cancer had progressed. How much does that change the treatment?
Mimi
Completely. Stage one cancer, caught early, can often be treated with surgery alone—you remove the tumor, keep the breast, move on. Stage three means the cancer has spread to lymph nodes, possibly beyond. Now you're looking at chemotherapy, radiation, maybe mastectomy. The survival odds drop sharply.
Mark
The article mentions Indian women get breast cancer 10 years earlier than Western women. Why is that?
Mimi
No one knows for certain. It could be genetics, reproductive patterns, diet, environmental factors. But the effect is clear: a 35-year-old Indian woman can develop breast cancer that a Western woman wouldn't see until 45. That's a huge difference when you're talking about screening guidelines.
Mark
So the screening guidelines—starting mammography at 40—might not be early enough for Indian women?
Mimi
That's the implication. If Indian women are getting cancer a decade earlier, waiting until 40 to start screening means you're already behind. You're catching cases that have had years to grow.
Mark
What happens now? Does the hospital expect more delays, or is screening picking back up?
Mimi
The article doesn't say. But the projection is grim: 230,000 new cases by 2026. If the pandemic delays persist, if women remain afraid, that number could represent a generation of women diagnosed at later stages. The real cost won't be visible for years.
O Pulso
- Hospital screenings at major oncology centers collapsed by 70 percent during lockdown, severing the early-detection lifeline for hundreds of thousands of women.
- By mid-2020, women who had waited six months to a year began arriving with cancers that had quietly advanced from treatable to life-threatening stages.
- India already carries one of the world's heaviest breast cancer burdens — 1.5 lakh diagnoses and 70,000 deaths annually — and projections show cases climbing to 2.3 lakh by 2026.
- Indian women develop breast cancer a full decade earlier than Western counterparts, making pandemic-driven delays especially dangerous for women in their thirties and forties.
- Oncologists are urging women to reclaim yearly mammography from age 40, insisting that the tools for survival exist — but only if women can be persuaded to walk back through hospital doors.
Each year, tens of thousands of Indian women die from breast cancer not because medicine lacks answers, but because the disease is found too late. The pandemic has deepened this ancient tragedy: fear of one illness has caused women to turn away from the care that might have caught another in time. Across India, the six-month silences of lockdown are now arriving at hospital doors as stage-two and stage-three diagnoses — a delayed reckoning that will shape survival statistics for years to come.
Breast cancer kills roughly 70,000 Indian women every year — not because the disease is beyond medicine's reach, but because it is so often found too late. The pandemic has made this worse. At Indraprastha Apollo Hospital in New Delhi, a department that once saw 600 women a month for screenings and follow-ups watched that number fall by 70 percent after lockdown began. Fear of Covid-19 kept women home, and the disease kept growing.
By August and September of 2020, the consequences became visible. Women who had delayed care by six months or more were arriving with stage-two and stage-three cancers — tumors that had crossed from the manageable into the dangerous. Senior surgical oncologist Ramesh Sarin recognized the pattern for what it was: a secondary crisis, one the pandemic had quietly seeded, whose full harvest would take years to measure.
India's breast cancer burden is already distinct from the West's. Indian women develop the disease roughly a decade earlier — half of all patients are between 40 and 50, and 12 percent are in their thirties. By 2026, annual diagnoses are projected to reach 2.3 lakh. Against that backdrop, the interruption of even one screening cycle carries enormous weight.
The path forward is not complicated. Yearly mammography from age 40, supplemented by ultrasound for women with dense tissue, remains the clearest route to catching cancer while it is still small and survivable. These are not rare or costly interventions — they are the foundation of modern oncology. The obstacle now is not medical but human: persuading women that the risk of returning to a hospital is smaller than the risk of staying away.
Breast cancer kills more women in India than almost any other malignancy. Every year, roughly 150,000 Indian women receive a diagnosis. About 70,000 of them die—not because the disease is untreatable, but because it arrives too late. By the time a woman walks into a hospital, the cancer has already metastasized beyond the point where surgery alone can save her. The pandemic has made this calculus worse.
At Indraprastha Apollo Hospital in New Delhi, the numbers tell a stark story. Before Covid-19 shuttered the country, the surgical oncology department saw about 200 women each month for follow-up appointments after treatment. Another 400 came for routine screening. These visits were the scaffolding of early detection—the chance to catch a tumor when it was still small, still confined, still survivable. Then the lockdown came. Fear of the virus kept women home. Hospital visits plummeted by 70 percent.
By August and September of 2020, the hospital began seeing the consequence. Women who had delayed their screening by six months, nine months, a year—they arrived with stage two and stage three cancers. The disease had progressed from a treatable early phase into something far more sinister. Ramesh Sarin, the hospital's senior consultant in surgical oncology, watched this unfold and understood what it meant: the pandemic was not just a public health crisis. It was creating a secondary crisis, one that would claim lives for years to come.
India's breast cancer burden is already heavier than the West's, and it arrives earlier. Indian women typically develop the disease a full decade before their American or European counterparts. Among Indian patients, 12 percent are between 30 and 40 years old. Half are between 40 and 50. These are women in the middle of their working lives, raising families, still building. By 2026, if current trends hold, India will diagnose 230,000 new cases annually—a number that matches the developed world's rate, despite India's far larger population and fewer resources to treat it.
The science of early detection is not mysterious. A woman who begins yearly mammography at age 40 has a genuine chance of catching cancer when it is still localized, still operable, still survivable with breast-conserving surgery. Women with dense breast tissue benefit from ultrasound alongside mammography. These are not exotic interventions. They are the baseline of modern oncology. Yet they require a woman to walk into a hospital, to sit in a waiting room, to trust that the building will not infect her with a virus that kills.
The pandemic forced an impossible choice: ignore a lump, or risk Covid-19. Thousands of Indian women chose to wait. Now they are arriving with cancers that have already spread to lymph nodes, to distant organs. The window for cure has narrowed. Some have closed it entirely. The question now is not whether early detection works—it does. The question is how many women will have to die before the fear recedes enough for them to seek it.
Citações Notáveis
Before the pandemic, the hospital saw 200 monthly follow-up visits and 400 screening visits. By August-September, visits had declined 70 percent, and women were presenting with stage two and three cancers.— Ramesh Sarin, Senior Consultant, Surgical Oncology, Indraprastha Apollo Hospitals
Indian women get breast cancer 10 years earlier than women in the West, and 50 percent of cases occur between ages 40-50.— Ramesh Sarin, Senior Consultant, Surgical Oncology, Indraprastha Apollo Hospitals
Quer a matéria completa?
Leia o original em India TV News ↗
Health & Medicine